Evidence map›Paper›PMID 20860820›Full record

Trial reportBMC family practice2010

The RISAP-study: a complex intervention in risk communication and shared decision-making in general practice.

Pia Kirkegaard, Adrian G K Edwards, Bo Hansen, Mette D Hansen, Morten S A Jensen, Torsten Lauritzen, Mette B Risoer, Janus L Thomsen

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC family practice, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01187056 (The RISAP-study), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01187056 nacompletednot on this map

The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice

TypeinterventionalSponsorUniversity of AarhusRan2007 to 2012Enrolled179ConditionsHigh Cholesterol, Cardiovascular DiseaseArmsTraining programme
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Pia KirkegaardSchool of Public Health, Dept, of General Practice, Aarhus University, Bartholins Alle 2, DK-8000 Aarhus C, Denmark. pia.kirkegaard@alm.au.dk
Adrian G K Edwards
Bo Hansen
Mette D Hansen
Morten S A Jensen
Torsten Lauritzen
Mette B Risoer
Janus L Thomsen
Aarhus University · DKCardiff Metropolitan University · GBUiT The Arctic University of Norway · NOUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGeneral practitioners (GPs) and patients find it difficult to talk about risk of future disease, especially when patients have asymptomatic conditions, and treatment options are unlikely to cause immediate perceptible improvements in well-being. Further studies in risk communication training are needed.

aim1) to systematically develop, describe and evaluate a complex intervention comprising a training programme for GPs in risk communication and shared decision-making, 2) to evaluate the effect of the training programme on real-life consultations between GPs and patients with high cholesterol levels, and 3) to evaluate patients' reactions during and after the consultations. METHODS/

designThe effect of the complex intervention, based around a training programme, will be evaluated in a cluster-randomised controlled trial with an intervention group and an active control group with 40 GPs and 280 patients in each group.The GPs will receive a questionnaire at baseline and after 6 months about attitudes towards risk communication and cholesterol-reducing medication. After each consultation with a participating high cholesterol-patient, the GPs will complete a questionnaire about decision satisfaction (Provider Decision Process Assessment Instrument). The patients will receive a questionnaire at baseline and after 3 and 6 months. It includes questions about adherence to chosen treatment (Morisky Compliance Scale), self-rated health (SF-12), enablement (Patient Enablement Instrument), and risk communication and decision-making effectiveness (COMRADE Scale). Prescriptions, contacts to the health services, and cholesterol level will be drawn from the registers.In each group, 12 consultations will be observed and tape-recorded. The patients from these 24 consultations will be interviewed immediately after the consultation and re-interviewed after 6 months.Eight purposefully selected GPs from the intervention group will be interviewed in a focus group 6 months after participation in the training programme.The process and context of the RISAP-study will be investigated in detail using an action research approach, in order to analyse adaptation of the intervention model to the specific context. DISCUSSION: This study aims at providing GPs and patients with a firm basis for active deliberation about preventive treatment options, with a view to optimising adherence to chosen treatment.

trial registrationClinicalTrials.gov Protocol Registration System NCT01187056.

Indexed as

HypercholesterolemiaPatient ParticipationAdultAttitude to HealthCommunicationFemaleGeneral PracticeHumansMalePhysicians, FamilyResearch DesignRisk

Identifiers

PMID20860820
PMCPMC2954954
OpenAlexW2108556906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.